Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study. (Q51367101)
Jump to navigation
Jump to search
scientific article published on 7 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study. |
scientific article published on 7 October 2011 |
Statements
1 reference
Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study. (English)
1 reference
M Nowicki
1 reference
H Haller
1 reference
M Warren
1 reference
L Suchower
1 reference
I Gause-Nilsson
1 reference
K-M Schützer
1 reference
7 October 2011
1 reference
65
1 reference
12
1 reference
1230-1239
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference